KathrynLurainMDMPH

PubMed

• Exacerbation of CMV and Nontuberculous Mycobacterial Infections Following PD-1 Blockade for HIV-Associated Kaposi Sarcoma.
  Shunsuke Sakai, Kelsie Brooks, Steven P Fling, Cecilia S Lindestam Arlehamn, Alessandro Sette, Kenneth S Knox, Jason M Brenchley, Daniel L Barber, Ifeanyichukwu U Anid...> ;Open Forum Infectious Diseases. 2024 May 1
• State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI.
  Eric A Engels, Meredith S Shiels, Ruanne V Barnabas, Julia Bohlius, Paul Brennan, Jessica Castilho, Stephen J Chanock, Megan A Clarke, Anna E Coghill, Jean-Damien Comb...> ;International Journal of Cancer. 2024 Feb 15
• Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis.
  Ramaswami, R., Tagawa, T., Mahesh, G., Serquina, A., Koparde, V., Lurain, K., Dremel, S., Li, X., Mungale, A., Beran, A., Ohler, Z., Bassel, L., Warner, A., Mangusan, ...> ;Journal of Translational Medicine. 2023 Sep 22
• 2 citations
  Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies.
  Roshani Patel, Kathryn Lurain, Ramya Ramaswami, Yarchoan, R.> ;Expert Review of Anti-Infective Therapy. 2023 Aug 15
• Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma.
  Lurain, K., Ramaswami, R., Marshall, V., Castro, E., Labo, N., Miley, W., Moore, K., Roshan, R., Mangusan, R., Jaffe, E., Pittaluga, S., Wang, H., Roth, M., Filie, A.,...> ;Haematologica. 2023 Jul 1
• 'A novel approach for characterisation of KSHV-associated multicentric Castleman disease from effusions': Response.
  Constance M Yuan, Kathryn Lurain, Maryalice Stetler-Stevenson, Armando C Filie, Stefania Pittaluga, Elaine S Jaffe, Ramya Ramaswami, Hao-Wei Wang, Zhou, T., Yarchoan, R.> ;British Journal of Haematology. 2023 Apr 1
• 4 citations
  A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.
  Ting Zhou, Constance M Yuan, Kathryn Lurain, Clarissa Rous, Linda Weaver, Mark Raffeld, Maryalice Stetler-Stevenson, Thomas S Uldrick, Armando C Filie, Stefania Pittal...> ;British Journal of Haematology. 2023 Feb 1
• 2 citations
  Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease.
  Prabha Shrestha, Yana Astter, David A Davis, Constance M Yuan, Ramya Ramaswami, Hao-Wei Wang, Kathryn Lurain, Zhou, T., Yarchoan, R.> ;Oncoimmunology. 2023 Jan 1
• 6 citations
  Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer.
  Thomas A Odeny, Kathryn Lurain, Julius Strauss, Steven P Fling, Elad Sharon, Anna Wright, Javier Martinez-Picado, Teresa Moran, James L Gulley, Maria Gonzalez-Cao, Tho...> ;Journal for Immunotherapy of Cancer. 2022 Sep 1
• Leveraging fine-needle aspiration to improve HIV-associated lymphoma diagnostic capacity in resource-limited settings.
  Kathryn Lurain, Thomas S Uldrick, José-Tomás Navarro> ;AIDS. 2022 Aug 1
• 4 citations
  Immunotherapy for KSHV-associated diseases.
  Kathryn Lurain, Ramya Ramaswami, Yarchoan, R.> ;Current Opinion in Virology. 2022 Aug 1
• 3 citations
  Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases.
  Megan E Hansen, Ralph Mangusan, Kathryn Lurain, Thomas Odeny, Jomy George, Crystal Lu, Maura Manion, Anaida Widell, Irene Ekwede, Denise Whitby, James L Gulley, Sameer...> ;AIDS. 2022 Nov 15
• 1 citations
  De-escalating Chemotherapy for Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Step Toward Improved Treatment of a Rare Virus-Associated Cancer.
  Kathryn Lurain, Thomas S Uldrick> ;JAMA Oncology. 2022 Jul 1
• 2 citations
  A Mixed Blood-Lymphatic Endothelial Cell Phenotype in Lymphangioleiomyomatosis and Idiopathic Pulmonary Fibrosis but Not in Kaposi's Sarcoma or Tuberous Sclerosis Comp...
  Gustavo Pacheco-Rodriguez, Connie G Glasgow, Yoshihiko Ikeda, Wendy K Steagall, Zu-Xi Yu, Katsuya Tsukada, Brent W Beasley, Bernadette R Gochuico, Gulsun Erdag, Kathry...> ;American Journal of Respiratory Cell and Molecular Biology. 2022 Mar 1
• 14 citations
  Oncologic Treatment of HIV-Associated Kaposi Sarcoma 40 Years on.
  Ramya Ramaswami, Kathryn Lurain, Robert Yarchoan> ;Journal of Clinical Oncology. 2022 Jan 20
• 7 citations
  How immunodeficiency can lead to malignancy.
  Sung-Yun Pai, Kathryn Lurain, Yarchoan, R.> ;Hematology. American Society of Hematology. Education Program. 2021 Dec 10
• 16 citations
  Safety, activity, and long-term outcomes of pomalidomide in the treatment of Kaposi sarcoma among individuals with or without HIV infection.
  Ramya Ramaswami, Mark N. Polizzotto, Kathryn Lurain, Kathleen M. Wyvill, Anaida Widell, Jomy M. George, Priscila H. Goncalves, Seth M. Steinberg, Denise Whitby, Thomas...> ;Clinical Cancer Research. 2021 Dec 3
• 5 citations
  HIV-associated malignancies at 40: much accomplished but much to do.
  Ramya Ramaswami, Kathryn Lurain> ;Global Health & Medicine. 2021 Aug 31
• 26 citations
  Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.
  , , , , , , , , , , , , , , , , , > ;Blood Advances. 2021 Mar 23
• Does HIV undermine breast cancer outcomes in women
  Kathryn Lurain, Sam M. Mbulaiteye> ;AIDS. 2021 Mar 15
• 24 citations
  Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma
  Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan, Anaida Widell, Irene Ekwede, Jomy M. George, Richard F. Ambinder, Martin A. Cheever, James L. Gulley, Priscila H. Gonc...> ;Journal for Immunotherapy of Cancer. 2021 Feb 1
• 3 citations
  Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders.
  Ramaswami, R., Lurain, K., Marshall, V., Rupert, A., Labo, N., Cornejo-Castro, E., Miley, W., Wang, H., Widell, A., Lindsley, M., Yuan, C., Stetler-Stevenson, M., Fili...> ;AIDS. 2021 Jan 1
• 16 citations
  Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical Trials.
  Joshua E. Reuss, Diana Stern, Jared C. Foster, Ramya Ramaswami, Kathryn Lurain, Helen X. Chen, Howard Streicher, Ravie Kem, Richard F. Little, Elad Sharon> ;JAMA Network Open. 2020 Dec 1
• 14 citations
  Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexate
  , , , , , , , , , , , , , , , > ;Blood. 2020 Nov 5
• 21 citations
  Anti-PD-1 and Anti-PD-L1 Monoclonal Antibodies in People Living with HIV and Cancer.
  Kathryn Lurain, Ramya Ramaswami, Robert Yarchoan, Thomas S. Uldrick> ;Current HIV/AIDS Reports. 2020 Oct 1
• Join now to see all

Journal Articles

• Discovery of Kaposi’s Sarcoma Herpesvirus-Encoded Circular RNAs and a Human Antiviral Circular RNA  
  Ramya Ramaswami, Kathryn Lurain, Thomas S Uldrick, Proceedings of the National Academy of Sciences

Lectures

• Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R2) in Primary Effusion Lymphoma in Patients with or without HIV 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019